NIH Awards Cerebral Amyloid Angiopathy Grant to Amydis Diagnostics
09 oct. 2017 09h14 HE
|
Amydis Diagnostics, Inc.
SAN DIEGO, Oct. 09, 2017 (GLOBE NEWSWIRE) -- Amydis Diagnostics, Inc., a privately-held pharmaceutical company developing proprietary chemistry and innovative approaches for the detection of...
Amydis Diagnostics Named to San Diego Venture Group’s (SDVG) 2017 Cool Companies List
30 mai 2017 09h00 HE
|
Amydis Diagnostics, Inc.
SAN DIEGO, May 30, 2017 (GLOBE NEWSWIRE) -- Amydis Diagnostics, Inc., a preclinical stage, privately-held pharmaceutical company developing proprietary chemistry and innovative approaches to...
Amydis Diagnostics Adds Veteran Drug Development Executive and Chief Medical Officer to Management Team
17 mai 2017 09h00 HE
|
Amydis Diagnostics, Inc.
SAN DIEGO, May 17, 2017 (GLOBE NEWSWIRE) -- Amydis Diagnostics, Inc., a preclinical stage, privately-held pharmaceutical company developing proprietary chemistry and innovative approaches to...
Amydis Diagnostics Awarded NIH Grant to Further Investigate Innovative Technology for Early Detection of Alzheimer’s Disease
20 mars 2017 07h07 HE
|
Amydis Diagnostics, Inc.
SAN DIEGO, March 20, 2017 (GLOBE NEWSWIRE) -- Amydis Diagnostics, Inc., a preclinical stage, privately-held pharmaceutical company developing proprietary chemistry and innovative approaches to...
Amydis Diagnostics Awarded NIA-NIH Grant to Investigate Innovative Technology for Detection of Alzheimer's Disease
29 sept. 2015 09h00 HE
|
Amydis, Inc.
SAN DIEGO, Sept. 29, 2015 (GLOBE NEWSWIRE) -- Amydis Diagnostics, Inc., a preclinical stage, privately-held pharmaceutical company developing proprietary chemistry and innovative approaches to...